Employee Spotlight: Dr. Steiner named Editor in Chief of Genetics in Medicine
PreventionGenetics’ Chief Medical Officer, Dr. Robert Steiner, MD, FAAP, FACMG, has been named Editor in Chief of Genetics in Medicine (GIM) to succeed James P. Evans, MD, PhD, FACMG. Genetics in Medicine is the American College of Medical Genetics and Genomics’ monthly peer-reviewed journal. Dr. Steiner has been involved with GIM since 2000, when he began reviewing for the journal. Since 2004, Dr. Steiner has authored or coauthored various publications in the journal and was asked to serve as Biochemical Genetics Editor in 2006. In 2011, he became deputy editor of the journal.
A proud supporter of the Muscular Dystrophy Association, PreventionGenetics sponsored an employee to volunteer at MDA Summer Camp. MDA Summer Camp is a weeklong camp held across the United States designed for kids diagnosed with muscular dystrophy and related diseases. Campers are able to participate in a variety of camp activities including zip lining, swimming, paintball, bonfires, fishing, mini golf, a carnival, and much more! MDA Summer Camp provides campers with an opportunity to gain independence and fosters lifelong friendships with fellow campers at no cost to the families.
Early diagnosis of kidney disease is important for establishing optimal maintenance and treatment plans. This is why, at PreventionGenetics, we’re constantly striving to provide the best genetic tests.
New Features and Benefits of PGxomeⓇ Custom Panels
PGxome Custom Panels are PreventionGenetics’ whole exome-based sequencing panels that are fully customizable to fit your patients’ personalized needs. Any subset of nearly 5,000 clinically relevant genes on our test menu may be chosen. Reduced pricing, added features, and flexible test building options enhance quality and value for you and your patients. The innovative approach of PGxome Custom Panels provides a new level of flexibility in genetic testing.
Data must be saved even after a patient leaves a health care system and even after the patient dies. Data on individual patients from different health care systems must be combined. And the data must be available to health care providers, testing labs, and researchers. This is indeed a huge undertaking, and progress in the beginning will likely be slow, but the benefits to patients are enormous.